Company Filing History:
Years Active: 2013
Title: André Cordier: Innovator in Kidney Health
Introduction
André Cordier is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of kidney health through her innovative research and patent work. Her expertise lies in assessing glomerular alterations and damage in the kidney, which is crucial for improving patient outcomes.
Latest Patents
André Cordier holds a patent titled "Use of β-2-microglobulin to assess glomerular alterations and damage in the kidney." This invention focuses on a method of measuring β-2-microglobulin to evaluate kidney health, specifically glomerular function. This patent represents a significant advancement in the diagnostic capabilities for kidney-related conditions.
Career Highlights
Cordier is associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in nephrology. Her dedication to improving kidney health has positioned her as a key figure in this area of medical innovation.
Collaborations
André Cordier has worked alongside notable colleagues such as Gerard Maurer and Frank Dieterle. These collaborations have fostered a productive environment for research and development, leading to advancements in kidney health diagnostics.
Conclusion
André Cordier's contributions to kidney health through her patent and work at Novartis AG highlight her role as an innovator in the medical field. Her research continues to pave the way for improved diagnostic methods, ultimately benefiting patients worldwide.